Cargando…
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
The usefulness of serum CYFRA 21-1 (cytokeratin-19 fragments) in monitoring the recurrence of breast cancer and in evaluating therapeutic effects was studied retrospectively. The sera from 173 patients with primary breast cancer or recurrent disease were measured for CYFRA 21-1, carcinoembryonic ant...
Autores principales: | Nakata, B, Takashima, T, Ogawa, Y, Ishikawa, T, Hirakawa, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409884/ https://www.ncbi.nlm.nih.gov/pubmed/15280913 http://dx.doi.org/10.1038/sj.bjc.6602074 |
Ejemplares similares
-
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003) -
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020) -
Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995) -
Clinical Usefulness of CYFRA Assay in Diagnosing Lung Cancer: Measurement of Serum Cytokeratin Fragment
por: Sugama, Yasuo, et al.
Publicado: (1994) -
Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer
por: Giovanella, L., et al.
Publicado: (2017)